US equities |
MU $1,015.87 ▼-2.84% NVDA $237.74 ▼-0.63% AMD $646.62 ▼-0.43% INTC $113.45 ▲+0.84% SPCX $170.76 ▼-0.67% SNDK $1,636.58 ▼-1.44% AAPL $333.89 ▲+0.08% MRVL $279.70 ▼-2.55%
FinancialContent

Latest News about #ATTRCM

Recent news which mentions #ATTRCM

2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Tickers CME
Tags Cardiology HFSA Hazlet
From PRLog
2025 HFM Symposium - Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
Tickers CME
Tags #ATTRCM Cardiomyopathy Cme
From PRLog